Inmode Ltd
NASDAQ:INMD

Watchlist Manager
Inmode Ltd Logo
Inmode Ltd
NASDAQ:INMD
Watchlist
Price: 19.02 USD 2.89% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Inmode Ltd?
Write Note

Inmode Ltd
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Inmode Ltd
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Inmode Ltd
NASDAQ:INMD
Net Issuance of Common Stock
-$164m
CAGR 3-Years
-177%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Nano-X Imaging Ltd
NASDAQ:NNOX
Net Issuance of Common Stock
$28m
CAGR 3-Years
-51%
CAGR 5-Years
50%
CAGR 10-Years
N/A
B
Brainsway Ltd
TASE:BWAY
Net Issuance of Common Stock
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sisram Medical Ltd
HKEX:1696
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sofwave Medical Ltd
TASE:SOFW
Net Issuance of Common Stock
$4k
CAGR 3-Years
-88%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Epitomee Medical Ltd
TASE:EPIT
Net Issuance of Common Stock
$43k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Inmode Ltd
Glance View

Market Cap
1.6B USD
Industry
Health Care

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. The company designs, develops, manufactures and commercializes energy-based, minimally-invasive surgical aesthetic and medical treatment solutions. The Company’s proprietary technologies are used by physicians to remodel subdermal adipose, or fatty, tissue in a variety of procedures including fat reduction with simultaneous skin tightening, face and body contouring and ablative skin rejuvenation treatments. Its products target a wide array of procedures including simultaneous fat killing and skin tightening, permanent hair reduction, skin appearance and texture, among others. The Company’s products may be used on a variety of body parts, including the face, neck, abdomen, upper arms, thighs and intimate feminine regions. The company owns six product platforms: BodyTite, Optimas, Votiva, Contoura, Triton and EmbraceRF. All are market and sell traditionally to plastic and facial surgeons, aesthetic surgeons and dermatologists, among others.

INMD Intrinsic Value
23.16 USD
Undervaluation 18%
Intrinsic Value
Price

See Also

What is Inmode Ltd's Net Issuance of Common Stock?
Net Issuance of Common Stock
-164m USD

Based on the financial report for Sep 30, 2024, Inmode Ltd's Net Issuance of Common Stock amounts to -164m USD.

What is Inmode Ltd's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 3Y
-177%

The average annual Net Issuance of Common Stock growth rates for Inmode Ltd have been -177% over the past three years .

Back to Top